Azenta Retained Earnings (Accumulated Deficit) 2010-2025 | AZTA
Azenta retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
| Azenta Annual Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2024 | $1,477 |
| 2023 | $1,641 |
| 2022 | $1,655 |
| 2021 | $-470 |
| 2020 | $-551 |
| 2019 | $-586 |
| 2018 | $-994 |
| 2017 | $-1,082 |
| 2016 | $-1,117 |
| 2015 | $-1,020 |
| 2014 | $-1,007 |
| 2013 | $-1,016 |
| 2012 | $-993 |
| 2011 | $-1,108 |
| 2010 | $-1,234 |
| 2009 | $-1,293 |
| Azenta Quarterly Retained Earnings (Accumulated Deficit) (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,423 |
| 2024-12-31 | $1,463 |
| 2024-09-30 | $1,477 |
| 2024-06-30 | $1,482 |
| 2024-03-31 | $1,488 |
| 2023-12-31 | $1,625 |
| 2023-09-30 | $1,641 |
| 2023-06-30 | $1,638 |
| 2023-03-31 | $1,639 |
| 2022-12-31 | $1,644 |
| 2022-09-30 | $1,655 |
| 2022-06-30 | $1,676 |
| 2022-03-31 | $1,686 |
| 2021-12-31 | $-434 |
| 2021-09-30 | $-470 |
| 2021-06-30 | $-484 |
| 2021-03-31 | $-516 |
| 2020-12-31 | $-532 |
| 2020-09-30 | $-551 |
| 2020-06-30 | $-573 |
| 2020-03-31 | $-579 |
| 2019-12-31 | $-581 |
| 2019-09-30 | $-586 |
| 2019-06-30 | $-991 |
| 2019-03-31 | $-992 |
| 2018-12-31 | $-988 |
| 2018-09-30 | $-994 |
| 2018-06-30 | $-997 |
| 2018-03-31 | $-1,013 |
| 2017-12-31 | $-1,073 |
| 2017-09-30 | $-1,082 |
| 2017-06-30 | $-1,093 |
| 2017-03-31 | $-1,103 |
| 2016-12-31 | $-1,110 |
| 2016-09-30 | $-1,117 |
| 2016-06-30 | $-1,121 |
| 2016-03-31 | $-1,122 |
| 2015-12-31 | $-1,032 |
| 2015-09-30 | $-1,020 |
| 2015-06-30 | $-1,020 |
| 2015-03-31 | $-1,021 |
| 2014-12-31 | $-1,017 |
| 2014-09-30 | $-1,007 |
| 2014-06-30 | $-1,001 |
| 2014-03-31 | $-1,020 |
| 2013-12-31 | $-1,018 |
| 2013-09-30 | $-1,016 |
| 2013-06-30 | $-1,017 |
| 2013-03-31 | $-1,013 |
| 2012-12-31 | $-1,007 |
| 2012-09-30 | $-993 |
| 2012-06-30 | $-1,103 |
| 2012-03-31 | $-1,109 |
| 2011-12-31 | $-1,113 |
| 2011-09-30 | $-1,108 |
| 2011-06-30 | $-1,117 |
| 2011-03-31 | $-1,184 |
| 2010-12-31 | $-1,210 |
| 2010-09-30 | $-1,234 |
| 2010-06-30 | $-1,258 |
| 2010-03-31 | $-1,274 |
| 2009-12-31 | $-1,295 |
| 2009-09-30 | $-1,293 |
| 2009-06-30 | $-1,278 |
| 2009-03-31 | $-1,252 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.410B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.946B | 59.99 |
| Hims & Hers Health (HIMS) | United States | $12.884B | 133.86 |
| Tempus AI (TEM) | United States | $12.253B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.705B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.914B | 61.16 |
| Privia Health (PRVA) | United States | $2.805B | 191.75 |
| Hinge Health (HNGE) | United States | $2.743B | 0.00 |
| Schrodinger (SDGR) | United States | $1.958B | 0.00 |
| Enovis (ENOV) | United States | $1.904B | 10.62 |
| Phreesia (PHR) | United States | $1.677B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.511B | 0.00 |
| Omnicell (OMCL) | United States | $1.424B | 25.12 |
| 10x Genomics (TXG) | United States | $1.327B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.661B | 0.00 |
| Claritev (CTEV) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.623B | 0.00 |
| Talkspace (TALK) | United States | $0.518B | 154.75 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Standard BioTools (LAB) | United States | $0.410B | 0.00 |
| TruBridge (TBRG) | United States | $0.372B | 824.67 |
| Outset Medical (OM) | United States | $0.362B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.276B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Pulmonx (LUNG) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.112B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 3.61 |
| 111 (YI) | China | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.027B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |